🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In patients with previously untreated Marginal zone lymphoma (MZL), a treat...
Status
Active Not Recruiting
Location
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, beijing,
Start Date
2025-10-01
Trial ID
NCT07480863
Treatments Being Tested
The goal of this clinical trial is to test the overall response rate of Ore...
Status
Recruiting
Location
The Second Affiliated Hospital of Zhejiang University, Ningbo First Hospital
Start Date
2023-01-02
Trial ID
NCT06134284
Treatments Being Tested
This study is a multi-center, open-label, single-arm, non-randomized phase ...
Status
Unknown
Location
Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
Start Date
2022-04-15
Trial ID
NCT05322733
Treatments Being Tested
This is a prospective single arm phase II study, and the purpose of this st...
Status
Recruiting
Location
China Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences
Start Date
2024-07-11
Trial ID
NCT06513234
Treatments Being Tested
This is a multi-center, prospective study. The main purpose is to evaluate ...
Status
Recruiting
Location
The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University#Huai'an First People's Hospital#
Start Date
2024-08-25
Trial ID
NCT06566807
Treatments Being Tested
This study aims to evaluate the safety and efficacy of orelabrutinib (O) in...
Status
Recruiting
Location
Changzhou Second People's Hospital
Start Date
2026-07-15
Trial ID
NCT07719556
Treatments Being Tested
This study focuses on treatment-naïve marginal zone lymphoma (MZL) patients...
Status
Recruiting
Location
Beijing Tongren Hospital
Start Date
2025-11-25
Trial ID
NCT07355699
Treatments Being Tested
Marginal zone lymphoma (MZL) is a common type of indolent lymphoma that ori...
Status
Recruiting
Location
Shanghai Ruijin Hospital
Start Date
2025-01-23
Trial ID
NCT06793189
This is a multicenter prospective single arm phase II study, and the purpos...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2024-06-20
Trial ID
NCT06454968
Treatments Being Tested
This is a multi-center, prospective cohort study. The main purpose of Cohor...
Status
Recruiting
Location
The First Affiliated Hospital ，Zhejiang University School of Medicine
Start Date
2024-06-28
Trial ID
NCT06504940